🎉 So proud of my wife Natasha Pinto Medici on her latest co–first author paper in @ScienceTransMed! 🚀 Her team introduces TMAB3 — a tumor-targeted, RNA-binding antibody that delivers RNA directly into tumors after systemic injection. www.science.org/doi/10.1126/...

Way to go, @xiangyuge.bsky.social, for a fantastic talk on how #PI3K governs resistance to #KRAS inhibition in #PancreaticCancer cells @faseborg.bsky.social Protein Phosphorylation! @yalepathology.bsky.social @yalecancer.bsky.social. Check out her preprint: www.biorxiv.org/content/10.1...

PI3K takes the spotlight when KRAS is inhibited in PDAC. Fantastic preprint from @xiangyuge.bsky.social now up!

🔁 Check out our new preprint exploring how dietary fats influence pancreatic cancer progression through ferroptosis sensitivity! 🦠🔥 In our model, MUFAs promote tumorigenesis, while PUFAs show protective effects. Read more here 📄👇 #CancerResearch #Ferroptosis #LipidMetabolism #bioRxiv”